Spatial intra-tumor heterogeneity is associated with survival of lung adenocarcinoma patients

Hua Jun Wu, Daniel Temko, Zoltan Maliga, Andre L. Moreira, Emi Sei, Darlan Conterno Minussi, Jamie Dean, Charlotte Lee, Qiong Xu, Guillaume Hochart, Connor A. Jacobson, Clarence Yapp, Denis Schapiro, Peter K. Sorger, Erin H. Seeley, Nicholas Navin, Robert J. Downey, Franziska Michor

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Intra-tumor heterogeneity (ITH) of human tumors is important for tumor progression, treatment response, and drug resistance. However, the spatial distribution of ITH remains incompletely understood. Here, we present spatial analysis of ITH in lung adenocarcinomas from 147 patients using multi-region mass spectrometry of >5,000 regions, single-cell copy number sequencing of ∼2,000 single cells, and cyclic immunofluorescence of >10 million cells. We identified two distinct spatial patterns among tumors, termed clustered and random geographic diversification (GD). These patterns were observed in the same samples using both proteomic and genomic data. The random proteomic GD pattern, which is characterized by decreased cell adhesion and lower levels of tumor-interacting endothelial cells, was significantly associated with increased risk of recurrence or death in two independent patient cohorts. Our study presents comprehensive spatial mapping of ITH in lung adenocarcinoma and provides insights into the mechanisms and clinical consequences of GD.

Original languageEnglish (US)
Article number100165
JournalCell Genomics
Volume2
Issue number8
DOIs
StatePublished - Aug 10 2022

Keywords

  • intra-tumor heterogeneity
  • lung adenocarcinoma
  • mass spectrometry
  • single-cell sequencing

ASJC Scopus subject areas

  • Genetics
  • Biochemistry, Genetics and Molecular Biology (miscellaneous)

MD Anderson CCSG core facilities

  • SINGLE Core

Fingerprint

Dive into the research topics of 'Spatial intra-tumor heterogeneity is associated with survival of lung adenocarcinoma patients'. Together they form a unique fingerprint.

Cite this